Union Life Sciences Ltd., 24 Cornhill, London, EC3V 3ND, UK.
J Med Chem. 2012 Apr 12;55(7):3513-20. doi: 10.1021/jm300203r. Epub 2012 Mar 28.
A β-carbonic anhydrase (CA, EC 4.2.1.1) from the fungal pathogen Malassezia globosa has been cloned, characterized, and studied for its inhibition with sulfonamides. This enzyme, designated MG-CA, has significant catalytic activity in the CO(2) hydration reaction and was inhibited by sulfonamides, sulfamates, and sulfamides with K(I) in the nanomolar to micromolar range. Several sulfonamides have also been investigated for the inhibition of growth of M. globosa, M. dermatis, M. pachydermatic, and M. furfur in cultures, whereas a mouse model of dandruff showed that treatment with sulfonamides led to fragmented fungal hyphae, as for the treatment with ketoconazole, a clinically used antifungal agent. These data prompt us to propose MG-CA as a new antidandruff drug target.
从真菌病原体马拉色菌中克隆、表征了一种β-碳酸酐酶(CA,EC 4.2.1.1),并研究了其与磺胺类药物的抑制作用。这种酶被命名为 MG-CA,在 CO(2)水合反应中具有显著的催化活性,并被磺胺类、磺胺酸盐和磺胺类药物以纳摩尔到微摩尔的范围抑制。还研究了几种磺胺类药物对马拉色菌、糠秕马拉色菌、皮脂马拉色菌和厚皮马拉色菌在培养物中的生长抑制作用,而头皮屑的小鼠模型表明,磺胺类药物治疗导致真菌菌丝碎片化,与临床使用的抗真菌药物酮康唑的治疗效果相同。这些数据促使我们提出 MG-CA 作为一种新的去屑药物靶点。